Looking for a true health and wellness reset? Look for these amenities when booking a luxury wellness retreat.
Ted Turner’s death comes at a fraught time for cable news, which has struggled to retain viewership in an era of countless ...
Appointment comes as banks and buy-side firms accelerate deployment of workflow-specific AI across deal execution, research, and investment processes ...
Haypp Group, parent company of Nicokick.com and Northerner.com, participated in the American Tobacco and Nicotine Forum (ATNF), held April 20-22, in Ashburn, Virginia. This press release features ...
Ted Turner, the pioneer of 24-hour news, profoundly shaped the media landscape and global news consumption. His innovative ...
Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...
Multiple dapagliflozin generic approvals are expected to intensify near-term market competition, requiring manufacturers to coordinate production readiness, launch timing, and labeling compliance ...
Generics Awareness Month took center stage at the Mercury Drug Q-Plaza Branch in Cainta recently, where RHEA Generics, in support of the Department of Health (DOH) and in partnership with Mercury Drug ...
NEW DELHI: A wave of affordable generic versions of Ozempic and Wegovy (semaglutide) has rapidly captured around 20% of the nearly Rs 1,600 crore weight-loss market within days of launch, following ...
The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...
Apotex Inc. has won tentative approval from the U.S. Food and Drug Administration for a cheaper, generic form of Ozempic six years before the patent expires there, while no generic versions have been ...
LOWERING DRUG COSTS — Bipartisan lawmakers have revived efforts to require Medicare to cover generic drugs — and at least two biosimilars — with patients paying lower costs than for brand-name drugs, ...